Key Events This Week
23 Mar: New 52-week low at Rs.147 amid sustained downtrend
23 Mar: Intraday low of Rs.146.3 amid price pressure
25 Mar: Intraday high surge of 7.01% to Rs.154.35
27 Mar: Intraday low near 52-week bottom at Rs.142
23 March 2026: Stock Hits 52-Week Low Amid Broad Market Weakness
Dishman Carbogen Amcis Ltd’s stock price plunged to a fresh 52-week low of Rs.147 on 23 March 2026, closing down 9.96% at Rs.142.85. This sharp decline was part of a three-day losing streak, with the stock falling 14.14% over that period. The intraday low touched Rs.146.3, reflecting intense selling pressure. The Pharmaceuticals & Biotechnology sector also declined by 3.12%, while the Sensex dropped 3.13%, closing at 32,377.87.
The stock traded below all major moving averages, signalling a sustained bearish trend. Financially, the company faces challenges with a low Return on Capital Employed (ROCE) of 0.97%, high leverage with a Debt to EBITDA ratio of 4.96, and a net loss after tax of Rs. -12.97 crores in the recent quarter. Institutional investors reduced holdings by 0.51% in the previous quarter, reflecting waning confidence.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
24 March 2026: Modest Recovery Amid Market Rally
On 24 March, the stock rebounded slightly, gaining 0.88% to close at Rs.144.10 on lower volume of 34,372 shares. This modest recovery coincided with a broader market rally, as the Sensex surged 1.95% to 33,009.57. The Pharmaceuticals & Biotechnology sector also advanced 2.49%, reflecting improved sentiment. However, the stock remained below all key moving averages, indicating that the broader downtrend was intact despite the short-term bounce.
25 March 2026: Intraday High and Outperformance
Dishman Carbogen Amcis Ltd recorded a notable intraday high of Rs.154.35 on 25 March 2026, surging 7.01% during the session and closing at Rs.153.95, a 6.84% gain from the previous close. This rally outpaced the Pharmaceuticals & Biotechnology sector’s 2.49% gain and the Sensex’s 1.93% rise to 33,645.89. The two-day consecutive gain streak amounted to a 7.7% return, offering a brief respite from the prior losses.
Despite this surge, the stock remained below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling that the technical outlook remained cautious. MarketsMOJO’s Mojo Score of 17.0 and Strong Sell rating, updated in January 2026, continued to reflect the stock’s risk profile amid ongoing financial and technical challenges.
Why settle for Dishman Carbogen Amcis Ltd? SwitchER evaluates this small-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
27 March 2026: Sharp Decline Near 52-Week Low Amid Renewed Selling
The week closed on a weak note as Dishman Carbogen Amcis Ltd’s stock fell 7.11% to Rs.143.00 on 27 March 2026, touching an intraday low of Rs.142. This represented a 7.24% intraday decline and placed the stock just 1.23% above its 52-week low of Rs.141.05. The stock’s volatility was elevated, with intraday swings of 6.43%, reflecting heightened selling pressure.
The broader market was also weak, with the Sensex falling 2.11% to 32,935.19. The Pharmaceuticals & Biotechnology sector underperformed, contributing to the stock’s decline. Technical indicators remained bearish, with the stock trading below all major moving averages and negative signals from MACD, Bollinger Bands, and Dow Theory assessments. The Mojo Grade of Strong Sell remained unchanged, underscoring the stock’s challenging outlook.
Daily Price Comparison: Dishman Carbogen Amcis Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-03-23 | Rs.142.85 | -9.96% | 32,377.87 | -3.13% |
| 2026-03-24 | Rs.144.10 | +0.88% | 33,009.57 | +1.95% |
| 2026-03-25 | Rs.153.95 | +6.84% | 33,645.89 | +1.93% |
| 2026-03-27 | Rs.143.00 | -7.11% | 32,935.19 | -2.11% |
Key Takeaways
Persistent Downtrend: The stock’s 9.86% weekly decline far exceeded the Sensex’s 1.46% fall, reflecting sustained weakness and underperformance within the Pharmaceuticals & Biotechnology sector.
Technical Weakness: Trading below all major moving averages and bearish technical indicators such as MACD and Bollinger Bands signal continued selling pressure and limited near-term recovery prospects.
Financial Challenges: Weak profitability metrics, high leverage, and recent net losses have contributed to negative sentiment and reduced institutional interest.
Short-Term Volatility: The midweek rally on 25 March demonstrated potential for short-term rebounds, but the stock’s failure to sustain gains and renewed declines on 27 March highlight ongoing volatility and uncertainty.
Conclusion
Dishman Carbogen Amcis Ltd’s performance over the week ending 27 March 2026 was marked by significant volatility and a clear downward trajectory. Despite a brief rally midweek, the stock closed the week near its 52-week low, underperforming the broader market and its sector peers. The combination of weak financial fundamentals, bearish technical signals, and a challenging market environment has weighed heavily on the stock’s price. Investors should note the persistent selling pressure and cautious market sentiment that currently define the stock’s outlook.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
